Five percent dextrose maximizes dose delivery of Yttrium-90 resin microspheres and reduces rates of premature stasis compared to sterile water

Koran,Mary  Ellen; Stewart,Samantha; Baker,Jennifer   C.; Lipnik,Andrew   J.; Banovac,Fil; Omary,Reed   A.; Brown,Daniel   B.

doi:10.3892/br.2016.799

Five percent dextrose maximizes dose delivery of Yttrium-90 resin microspheres and reduces rates of premature stasis compared to sterile water

Authors:
- Mary Ellen Koran
- Samantha Stewart
- Jennifer C. Baker
- Andrew J. Lipnik
- Fil Banovac
- Reed A. Omary
- Daniel B. Brown
View Affiliations

Affiliations: Department of Radiology and Radiologic Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
Published online on: November 1, 2016 https://doi.org/10.3892/br.2016.799
Pages: 745-748

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Resin Yttrium-90 (Y90) microspheres have historically been infused using sterile water (H2O). In 2013, recommendations expanded to allow delivery with 5% dextrose in water (D5W). In this retrospective study, we hypothesized that D5W would improve Y90 delivery with a lower incidence of stasis. We reviewed 190 resin Y90 infusions using H2O (n=137) or D5W (n=53). Y90 dosimetry was calculated using the body surface area method. Infusion was halted if intra‑arterial stasis was fluoroscopically identified prior to clearing the vial. Differences between H2O and D5W groups were calculated for activity prescription, percentage of cases reaching stasis, and percentage delivery of prescribed activity using z‑ and t-test comparisons, with α=0.05. Thirty‑one of 137 H2O infusions developed stasis compared to 2 of 53 with D5W (z=3.07, p=1.05E‑03). D5W also had a significantly higher prescribed activity than H2O [28.2 millicuries (mCi) vs. 20.4 mCi, respectively; t=5.0, p=1.1E‑6]. D5W had a higher delivery percentage of the prescribed dose compared to H2O (101.5 vs. 92.7%, respectively; t=3.8, p=1.92E‑4). In conclusion, resin microsphere infusion utilizing D5W has a significantly lower rate of stasis than H2O and results in more complete dose delivery. D5W is preferable to H2O for resin microsphere infusion.

View Figures

View References

1	Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, et al: Radioembolization with 90Y microspheres: Angiographic and technical considerations. Cardiovasc Intervent Radiol. 30:571–592. 2007. View Article : Google Scholar : PubMed/NCBI
2	Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, et al: Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results. J Vasc Interv Radiol. 16:937–945. 2005. View Article : Google Scholar : PubMed/NCBI
3	Stuart JE, Tan B, Myerson RJ, Garcia-Ramirez J, Goddu SM, Pilgram TK and Brown DB: Salvage radioembolization of liver-dominant metastases with a resin-based microsphere: Initial outcomes. J Vasc Interv Radiol. 19:1427–1433. 2008. View Article : Google Scholar : PubMed/NCBI
4	Piana PM, Bar V, Doyle L, Anne R, Sato T, Eschelman DJ, McCann JW, Gonsalves CF and Brown DB: Early arterial stasis during resin-based yttrium-90 radioembolization: Incidence and preliminary outcomes. HPB Oxf. 16:336–341. 2014. View Article : Google Scholar
5	Saxena A, Meteling B, Kapoor J, Golani S, Morris DL and Bester L: Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients. Ann Surg Oncol. 22:794–802. 2015. View Article : Google Scholar : PubMed/NCBI
6	van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, Peeters M, Perez D, Robinson BA, Strickland AH, Ferguson T, et al: SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. J Clin Oncol. 34:1723–1731. 2016. View Article : Google Scholar : PubMed/NCBI
7	Food and Drug Administration, . Available at. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/ucm431264.htmAccessed on June 15, 2016.
8	Gordon AC, Gradishar WJ, Kaklamani VG, Thuluvath AJ, Ryu RK, Sato KT, Gates VL, Salem R and Lewandowski RJ: Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy. J Vasc Interv Radiol. 25:1523–1532, 1532. 2014. View Article : Google Scholar : PubMed/NCBI
9	Lewandowski RJ, Memon K, Mulcahy MF, Hickey R, Marshall K, Williams M, Salzig K, Gates VL, Atassi B, Vouche M, et al: Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: Survival by era and chemotherapy. Eur J Nucl Med Mol Imaging. 41:1861–1869. 2014. View Article : Google Scholar : PubMed/NCBI
10	Kennedy AS, Nutting C, Coldwell D, Gaiser J and Drachenberg C: Pathologic response and microdosimetry of (90)Y microspheres in man: Review of four explanted whole livers. Int J Radiat Oncol Biol Phys. 60:1552–1563. 2004. View Article : Google Scholar : PubMed/NCBI
11	Pierce LR, Gaines A, Finlayson JS, Varricchio F and Epstein JS: Hemolysis and acute renal failure due to the administration of albumin diluted in sterile water. Transfusion. 39:110–111. 1999. View Article : Google Scholar : PubMed/NCBI
12	Ramaswamykanive H and Greaves J: Intravenous infusion of sterile water for the treatment of hypernatraemia. Anaesth Intensive Care. 42:258–262. 2014.PubMed/NCBI
13	Liao JC, Hein TW, Vaughn MW, Huang KT and Kuo L: Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci USA. 96:8757–8761. 1999. View Article : Google Scholar : PubMed/NCBI
14	Vaughn MW, Huang KT, Kuo L and Liao JC: Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem. 275:2342–2348. 2000. View Article : Google Scholar : PubMed/NCBI
15	Rother RP, Bell L, Hillmen P and Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA. 293:1653–1662. 2005. View Article : Google Scholar : PubMed/NCBI
16	Clark DA, Butler SA, Braren V, Hartmann RC and Jenkins DE Jr: The kidneys in paroxysmal nocturnal hemoglobinuria. Blood. 57:83–89. 1981.PubMed/NCBI
17	Hirsch DP, Holloway RH, Tytgat GN and Boeckxstaens GE: Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. Gastroenterology. 115:1374–1380. 1998. View Article : Google Scholar : PubMed/NCBI
18	Sato KT, Omary RA, Takehana C, Ibrahim S, Lewandowski RJ, Ryu RK and Salem R: The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases. J Vasc Interv Radiol. 20:1564–1569. 2009. View Article : Google Scholar : PubMed/NCBI
19	Geschwind JF, Ramsey DE, Cleffken B, van der Wal BC, Kobeiter H, Juluru K, Hartnell GG and Choti MA: Transcatheter arterial chemoembolization of liver tumors: Effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Intervent Radiol. 26:111–117. 2003. View Article : Google Scholar : PubMed/NCBI
20	Chao C, Dagli M, Mondschein J, Stavropoulos W, Sudheendra D, Nadolski G, et al: Effect of substituting 50% issue for sterile water as the delivery medium for SIR-SPHERES: Improved dose delivery and decreased incidence of stasis. J Vasc Interv Radiol. 2:S892014. View Article : Google Scholar